| Are the Votes of Ethics Committees in Germany for the Protection of Clinical Study Trial Subjects "Sovereign Acts?" | |
| | |
MedLine Citation:
|
PMID: 21818624 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
A sudden paradigm shift has resulted in governmental measures that greatly impact the scope in which the ethics committees in Germany can perform their task of providing expert opinions for clinical research. The so-called "revaluation" of the Medical Device Law Deutsches Medizinproduktegesetz-MPG) is, in our opinion, not based on sound political and professional judgment. In accordance with the changed regulations, ethics committees are now seen as being sub-organs of the state medical associations or the medical faculties and are therefore official authorities. It follows that the votes of ethics committees are then "sovereign acts" or authoritative measures! However, equality and justice speak against this misleading conclusion and its resulting consequence that an ethics committee's vote is a sovereign act. This has, in turn, resulted in the public ethics committees obtaining their long-sought goal of having a state-sanctioned monopoly. The private ethics committees are not recognized as being authoritative bodies, nor are they to be seen as such in the future (i.e. such a status has been denied the Freiburg Ethics Commission International (FEKI) in Baden-Württemberg). This political mistake must be corrected, otherwise, conducting clinical research will become increasingly difficult. |
| | |
Authors:
|
Hans-Peter Graf |
Related Documents
:
|
22116564 - Priority setting in ontario's lhins: ethics and economics in action. 21741774 - Decency, honor, integrity, and the law. 15993064 - Radiosynthesis of carbon-11-labeled camptothecin derivatives as potential positron emis... 21906424 - Recommendations for the use of biologic therapy in rheumatoid arthritis: update from th... 21431804 - Does the japanese society for hygiene need its own code of conduct? a comparison of the... 21951454 - Ethical and legal aspects of management for disorders of sex development. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-8-5 |
Journal Detail:
|
Title: Science and engineering ethics Volume: - ISSN: 1471-5546 ISO Abbreviation: - Publication Date: 2011 Aug |
Date Detail:
|
Created Date: 2011-8-5 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9516228 Medline TA: Sci Eng Ethics Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
, Mozartstrasse 21, 79104, Freiburg, Germany, hp.graf@feki.com. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The spectral changes in EMG during a second bout eccentric contraction could be due to adaptation in...
Next Document: The anabolic steroid methandienone targets the hypothalamic-pituitary-testicular axis and myostatin ...